World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
20867
World Ranking
17233
National Ranking
8636

Overview

Daniel Medina is affiliated with Baylor College of Medicine in the United States and has contributed extensively to the field of medicine, with a particular focus on oncology, infectious diseases, molecular biology, genetics, and pulmonary and respiratory medicine. Their research spans key topics such as SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, cancer immunotherapy and biomarkers, RNA modifications and cancer, chronic lymphocytic leukemia research, cancer cells and metastasis, as well as ferroptosis and cancer prognosis.

The scientist's publication record includes research appearing predominantly in the journal Blood, with seven papers, and additional works published in Blood Advances, SSRN Electronic Journal, Nature, and the American Journal of Hematology.

Notable recent publications by Daniel Medina are:

  • Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies (2021, Blood Advances)
  • Nerve-to-cancer transfer of mitochondria during cancer metastasis (2025, Nature)
  • Kinetics of cellular and humoral immunogenicity and effectiveness of SARS-CoV-2 booster vaccination in hematologic neoplasms (2023, American Journal of Hematology)
  • Expression landscapes in non-small cell lung cancer shaped by the thyroid transcription factor 1 (2022, Lung Cancer)
  • The differential prognostic implications of PD-L1 expression in the outcomes of Filipinos with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors (2023, Translational Lung Cancer Research)

Frequent collaborators include Francesc Bosch, Marta Crespo, Gemma Pujadas, Cristina Hernández, and Pau Abrisqueta. Each of these coauthors has worked with Medina on multiple occasions, reflecting ongoing research partnerships.

Their interdisciplinary approach integrates clinical and molecular studies, focusing on immunogenicity in hematologic cancers and the molecular mechanisms underlying cancer progression and metastasis, particularly in lung cancer and other solid tumors. Research in COVID-19 vaccine responses within hematologic malignancies constitutes a significant portion of their recent work.

Best Publications

  • Prostate cancer in a transgenic mouse.

    N M Greenberg;F DeMayo;M J Finegold;D Medina

  • Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro

    Keith G. Danielson;Carol J. Oborn;Elisa M. Durban;Janet S. Butel

  • Identification of Tumor-initiating Cells in a p53 Null Mouse Model of Breast Cancer

    Mei Zhang;Fariba Behbod;Rachel L. Atkinson;Melissa D. Landis

  • Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.

    Lawrence A. Donehower;Lucy A. Godley;Lucy A. Godley;Claudio M Aldaz;Ruth Pyle

  • Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution

    D. Craig Allred;Yun Wu;Sufeng Mao;Iris D. Nagtegaal

  • Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells.

    Ilaria Taddei;Marie-Ange Deugnier;Marisa Martin Faraldo;Valérie Petit

  • Murine Mammary Gland Carcinogenesis Is Critically Dependent on Progesterone Receptor Function

    John P. Lydon;Gouqing Ge;Francis S. Kittrell;Daniel Medina

  • The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer

    D. Craig Allred;Powel H Brown;Daniel Medina

  • The mammary gland: a unique organ for the study of development and tumorigenesis.

    Daniel Medina

  • Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis.

    Elmar Stickeler;Frances Kittrell;Daniel Medina;Susan M Berget

  • Centrosome Amplification and Overexpression of Aurora A Are Early Events in Rat Mammary Carcinogenesis

    Thea M Goepfert;Yetunde E Adigun;Ling Zhong

  • Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells

    Jason I. Herschkowitz;Wei Zhao;Mei Zhang;Jerry Usary

  • Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.

    Charlotte Kuperwasser;Gregory D. Hurlbut;Frances S. Kittrell;Ellen S. Dickinson

  • An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ

    Fariba Behbod;Frances S Kittrell;Heather LaMarca;David Edwards

  • Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene.

    Betty L. Slagle;Teh Hsiu Lee;Daniel Medina;Milton J. Finegold

  • A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.

    D. J. Jerry;F. S. Kittrell;C. Kuperwasser;Rodolfo Laucirica

  • Angiogenesis. A marker for neoplastic transformation of mammary papillary hyperplasia.

    Steven S. Brem;Pietro M. Gullino;Daniel Medina

  • Re-evaluation of mammary stem cell biology based on in vivo transplantation.

    Gilbert H Smith;Daniel Medina

  • Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer.

    Sangjun Lee;Sheila Stewart;Iris Nagtegaal;Jingqin Luo

  • Overexpression of Separase induces aneuploidy and mammary tumorigenesis

    Nenggang Zhang;Gouquing Ge;Rene Meyer;Sumita Sethi

Frequent Co-Authors

Janet S. Butel
Janet S. Butel Baylor College of Medicine
Jeffrey M. Rosen
Jeffrey M. Rosen Baylor College of Medicine
D. Craig Allred
D. Craig Allred The University of Texas Health Science Center at San Antonio
Gilbert H. Smith
Gilbert H. Smith National Institutes of Health
Bert W. O'Malley
Bert W. O'Malley Baylor College of Medicine
Susan G. Hilsenbeck
Susan G. Hilsenbeck Baylor College of Medicine
Orla M. Conneely
Orla M. Conneely Baylor College of Medicine
Lawrence A. Donehower
Lawrence A. Donehower Baylor College of Medicine
Charles M. Perou
Charles M. Perou University of North Carolina at Chapel Hill
Michael T. Lewis
Michael T. Lewis Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine isn’t limited to traditional routes. Online degrees now offer flexible paths to launch or advance your healthcare career, often at a lower cost and with more convenience. Those interested in administrative roles can consider options with a medical coding certification cost that fits various budgets, providing a gateway to healthcare finance and records.

For aspiring clinicians, there are reputable and most affordable online nurse practitioner programs designed for working nurses who want to expand their practice or shift into advanced patient care. Others might benefit from the cheapest online nursing programs which can help secure RN or BSN credentials and open doors into entry-level healthcare positions.

For experienced nurses aiming for the highest levels of clinical or academic leadership, consider the cheapest online dnp programs. These pathways offer ways to boost career prospects, enhance expertise, and improve patient outcomes—all from the comfort of home.

Best Scientists Citing Daniel Medina

Trending Scientists